Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis.
- Published In:
- ACR open rheumatology, 7(9), e70103 (2025)
- Authors:
- Kellner, David A, Dente, Elizabeth, Tran, Vincent, Welsh, Travis, Tran, Victor, Saha, Angshuman, Baker, Joshua F, Elashoff, David A, Ranganath, Veena K
- Database ID:
- RPEP-11773
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11773APA
Kellner, David A; Dente, Elizabeth; Tran, Vincent; Welsh, Travis; Tran, Victor; Saha, Angshuman; Baker, Joshua F; Elashoff, David A; Ranganath, Veena K. (2025). Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis.. ACR open rheumatology, 7(9), e70103. https://doi.org/10.1002/acr2.70103
MLA
Kellner, David A, et al. "Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis.." ACR open rheumatology, 2025. https://doi.org/10.1002/acr2.70103
RethinkPeptides
RethinkPeptides Research Database. "Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patie..." RPEP-11773. Retrieved from https://rethinkpeptides.com/research/kellner-2025-effect-of-glucagonlike-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.